Please ensure Javascript is enabled for purposes of website accessibility
Contáctenos Contáctenos
ES
Inicio > Productos Destacados > Oncology Research > Melanoma

960 resultados de producto para "Melanoma"

Opciones+
Opciones
Confirmar
  • Tipos de productos
    0 seleccionado
    Assay Kit (419)
    Proteins (75)
    Biosimilars (1)
    Research Biosimilar (157)
    Antibodies (298)
    Stable Cell Lines (1)
  • Sistema de expresión
    0 seleccionado
    HEK293T (1)
    E. coli (35)
    Mammalian Cells (186)
  • Objetivo
    0 seleccionado
    Ipilimumab (2)
    GP/Envelope glycoprotein (4)
    T3E (1)
    Golimumab (3)
    Omburtamab (1)
    TAU pT181 (1)
    Evolocumab (1)
    EPO/Erythropoietin (1)
    Lupartumab (1)
    Toripalimab (1)
    Exenatide acetate (2)
    Pertuzumab (3)
    CD137/4-1BB/TNFRSF9& CD274/PD-L1/B7-H1 (1)
    Denosumab (3)
    US8/gE (1)
    Sibrotuzumab (1)
    Fluorescein & CD274/PD-L1 (1)
    Camidanlumab (1)
    Mazdutide (2)
    RBD (6)
    Varisacumab (1)
    RBD (Omicron/JN.1) (1)
    Lirilumab (1)
    CTLA4 & PD1 (2)
    Tesidolumab (1)
    Sirukumab (1)
    Rafivirumab (1)
    cAMP (1)
    RBD (WT) (1)
    Vorsetuzumab (1)
    G/Major surface glycoprotein G (1)
    Lexatumumab (1)
    Mirikizumab (2)
    PDL1 (6)
    Aflibercept (1)
    CD152/CTLA4 & CD274/PD-L1 (1)
    Zampilimab (1)
    NRAS (2)
    CD175/Tn (10)
    S100A6 (1)
    Omalizumab (2)
    HLA-A2-peptide (KTWGQYWQV) Complex (2)
    Favezelimab (1)
    CD86/B7-2 (26)
    Semorinemab (1)
    Talacotuzumab (1)
    S100A5 (4)
    Tremelimumab (1)
    gG/US4 (2)
    T-cell surface antigen T3/Leu-4 epsilon chain (1)
    Pasotuxizumab (1)
    TIGIT & CD274/PD-L1 (1)
    Cixutumumab (1)
    H3L (3)
    TAU pT217 (1)
    Andecaliximab (1)
    Alirocumab (1)
    Cinpanemab (1)
    CD274/PD-L1 & CD28 (1)
    TYR/Tyrosinase (2)
    Trastuzumab (2)
    Nirsevimab (1)
    CD47/MER6 & PDCD1 / PD-1 / CD279 (1)
    Obinutuzumab (2)
    Cetuximab (3)
    Ifabotuzumab (1)
    CD366/HAVCR2/TIM-3 (4)
    Spike glycoprotein E2 (2)
    Simlukafusp Alfa (1)
    LAG3 & PD-1 (1)
    Daclizumab (1)
    Enfortumab (1)
    Emibetuzumab (1)
    RBD (Delta) (3)
    FLT1/VEGFR1 & CD274/PD-L1 (1)
    RBD (Omicron/KP.2) (1)
    Tibulizumab (1)
    Ziltivekimab (1)
    VASH2/Vasohibin-2 (1)
    Carlumab (1)
    RBD (Alpha) (1)
    N/Nucleoprotein (1)
    Tigatuzumab (1)
    Glembatumumab (1)
    Lenzilumab (1)
    S100A14 (1)
    CD274/PD-L1 (81)
    Anifrolumab (1)
    S100a15a (1)
    CD152/CTLA4 & CD134/OX40 (1)
    Rituximab (1)
    CD274/PD-L1 & CD137/TNFRSF9 (1)
    S100A12 (1)
    Namilumab (1)
    Dilpacimab (1)
    Tilavonemab (1)
    Natalizumab (2)
    S100A8 (3)
    Vibecotamab (1)
    Zalifrelimab (1)
    gB/Envelope glycoprotein B (1)
    T-cell surface glycoprotein CD3 epsilon chain (1)
    Rosopatamab (2)
    Infliximab (2)
    Frovocimab (1)
    Dalotuzumab (1)
    E8L (5)
    S100A2 (1)
    Depatuxizumab (1)
    Retatrutide (1)
    Zanidatamab (1)
    Palivizumab (3)
    KITLG/SCF (1)
    Afutuzumab (1)
    sCD14 (1)
    CD366/TIM-3 (34)
    Spike glycoprotein E1 (2)
    Spike glycoprotein (10)
    Crizanlizumab (1)
    CD340/ERBB2 (1)
    Codrituzumab (1)
    Tanezumab (1)
    Vunakizumab (1)
    Tosatoxumab (1)
    SOX10 (3)
    RBD (Beta) (1)
    Meplazumab (1)
    Balstilimab (1)
    CD279/PD-1 & CD274/PD-L1 (1)
    CD137/4-1BB & CD274/PD-L1 & ROR1 & CD3 (1)
    S100A1 (2)
    Vofatamab (1)
    CD223/LAG3 & CD279/PD-1 (4)
    Abatacept (1)
    S100A13 (1)
    S100A4 (3)
    CD274/PD-L1 & CD152/CTLA4 (1)
    Indatuximab (1)
    S100B (9)
    CD223/LAG3 (41)
    Cetrelimab (1)
    DCT (2)
    Otilimab (1)
    Navicixizumab (1)
    VEGFA & B7-H1 / PD-L1 / CD274 (1)
    Zagotenemab (1)
    gE/Envelope glycoprotein E (1)
    Tarextumab (1)
    Lodelcizumab (1)
    PD-L1 & VEGF (1)
    Figitumumab (1)
    A35R (5)
    Farletuzumab (1)
    Ustekinumab (3)
    CD79B (2)
    Losatuxizumab (1)
    Afasevikumab (1)
    β-D-Glucan (1)
    Suptavumab (1)
    B7-H1 / PD-L1 / CD274 & CD3E (1)
    Epcoritamab (1)
    F/Fusion glycoprotein F0 (5)
    Letolizumab (1)
    dsRNA (1)
    Ibalizumab (1)
    Ianalumab (1)
    Tocilizumab (3)
    Spike Protein (Trimer) (2)
    Dupilumab (3)
    Inclacumab (1)
    IL1RL1/ST2 (1)
    VSIR/VISTA & CD274/PD-L1 (1)
    Cergutuzumab (1)
    cGMP (1)
    Lorvotuzumab (1)
    RBD (Gamma) (1)
    MITF (1)
    CD274/PD-L1 & CD3E (1)
    p-Tyr (1)
    Icrucumab (1)
    CD152/CTLA4 (86)
    CD274/PD-L1 & TGFBR2 (1)
    CD279/PD-1 & CD152/CTLA4 (4)
    Alacizumab (1)
    Faricimab (1)
    Nivolumab (3)
    Atezolizumab (3)
    Sotrovimab (1)
    MLANA (4)
    Edrecolomab (1)
    gD/Envelope glycoprotein D (1)
    Urelumab (1)
    Canakinumab (1)
    LAG-3 & PD-1 (1)
    Ganitumab (1)
    A29L (6)
    Mirvetuximab (1)
    B6R/SL-159 (1)
    CD274/PD-L1/B7-H1 (5)
    Necitumumab (1)
    Bimekizumab (1)
    Zenocutuzumab (1)
    Glofitamab (1)
    Guselkumab (3)
    ATP7B (1)
    Benufutamab (1)
    Amatuximab (1)
    Tregalizumab (1)
    PD-L1 & TGF-Beta (1)
    NP/Nucleocapsid (5)
    dsDNA (1)
    Astegolimab (1)
    Adalimumab (3)
    Tiragolumab (2)
    Labetuzumab (1)
    Obiltoxaximab (1)
    BSA (1)
    RBD (E484K) (1)
    CD274/PD-L1 & CD47/MER6 (1)
    CD274/PD-L1 & SLT-Ia (1)
    CD80/B7-1 (20)
    Oxelumab (1)
    TRP-1 & CD3e (1)
    S100P (1)
    CD223/LAG3 & CD152/CTLA4 (1)
    S100A10 (4)
    Lintuzumab (1)
    Protein A (1)
    Tisotumab (1)
    RBD (Kappa) (1)
    Ramucirumab (1)
    Nesvacumab (1)
    Pembrolizumab (3)
    mitF/aspF1 (1)
    Milatuzumab (1)
    Avelumab (3)
    Befovacimab (1)
    Casirivimab (1)
    Bimagrumab (1)
    gC/Envelope glycoprotein C (1)
    Utomilumab (1)
    Gevokizumab (1)
    Tezepelumab (1)
    Teprotumumab (1)
    IL6 (1)
    Bevacizumab (3)
    SARS-CoV-2 Neutralization Antibody (3)
    Ivuxolimab (1)
    PDL1 & VEGF (1)
    Panitumumab (3)
    Ixekizumab (1)
    Siltuximab (3)
    Suvizumab (1)
    CD47/MER6 & PDCD1 / PD-1 & CD137/4-1BB/TNFRSF9 (1)
    Ibritumomab (1)
    RBD (Omicron/BA.4/BA.5) (1)
    CD278/ICOS (1)
    Itolizumab (1)
    TPP15 (1)
    Anetumab (1)
    Zanolimumab (1)
    Blosozumab (1)
    Lacnotuzumab (1)
    Iscalimab (1)
    Olaratumab (1)
    Glycoprotein (5)
    PMEL17/ME20M (9)
    Asp f 1/mitF (1)
    CD274/PD-L1 & CD134/OX40 (1)
    CD274/PD-L1 & CD28 & CD152/CTLA4 (1)
    CD47/MER6 & CD274/PD-L1 (2)
    S100A16 (1)
    HLA-A2-peptide (TDQVPFSV) Complex (1)
    Ieramilimab (1)
    CD274/PD-L1 & VEGFA (1)
    TYRP1 (3)
    CD19 & PD-L1 & CD3E & CD137 (1)
    S100A9 (4)
    Cabiralizumab (1)
    Gremubamab (1)
    Human β Amyloid (1-42) (1)
    RBD (Delta Plus) (1)
    Spike glycoprotein (RBD) (1)
    Vanucizumab (1)
    Sintilimab (1)
    Glycoprotein G (2)
    Durvalumab (3)
    CD80&IL2 (1)
    Concizumab (1)
    Imdevimab (1)
    CD117/KIT (24)
    Rolinsatamab (1)
    gC/UL44 (1)
    Magrolimab (1)
    CD20/MS4A1 (3)
    Etanercept (3)
    Brolucizumab (1)
    RBD (Omicron/BA.5) (3)
    Pogalizumab (1)
    Serclutamab (1)
    Remtolumab (1)
    Clazakizumab (1)
    Mosunetuzumab (1)
    TPP17 (1)
    Conatumumab (1)
    Romosozumab (1)
    TYR (1)
    Romiplostim (2)
    Tovetumab (1)
    M/Matrix protein (2)
    CD3E (1)
    Belantamab (1)
    PD-L1 / VEGF-A (1)
    Certolizumab (2)
    Enoblituzumab (1)
    Oleclumab (1)
    IDO1 (2)
    CD366/TIM-3 & CD279/PD-1 (2)
    Sarilumab (2)
    CD152/CTLA4 & CD279/PD-1 (1)
    HLA-A2-peptide (ITDQVPFSV) Complex (4)
    EGFR & CD3E & PD-L1 & 4-1BB (1)
    CD366/TIM-3 & CD274/PD-L1 (1)
    TRP-1 & CD47/MER6 (1)
    CD274/PD-L1 & CD279/PD-1 (1)
    Mirzotamab (1)
    CD223 (1)
    Emactuzumab (1)
    M1R (5)
    Human β Amyloid (1-40) (1)
    Imalumab (1)
    Semaglutide (2)
    Ascrinvacumab (1)
    TFF3 (1)
    Tislelizumab (1)
    Disitamab (1)
    Pacmilimab (1)
    TDP2 (1)
    Marstacimab (1)
    Daratumumab (3)
    gD/US6 (1)
    Basiliximab (1)
    Elezanumab (1)
    Apamistamab (1)
    Ranibizumab (3)
    NP/Nucleoprotein (3)
    Tavolimab (1)
    Secukinumab (2)
    Imlifidase (5)
    Olokizumab (1)
    Foravirumab (1)
    CD47/MER6 & CD274/PD-L1/B7-H1 (2)
    Ocaratuzumab (1)
    Elotuzumab (1)
    Cusatuzumab (1)
    TPP47 (1)
    Drozitumab (1)
    Ontamalimab (1)
    Eldelumab (1)
    Sacituzumab (1)
    Eculizumab (3)
    Varlilumab (1)
    Tirzepatide (2)
    gp100 peptide-HLA Complex (1)
    Teclistamab (1)
    CD274/PD-L1 & TGFBR2/TGFR-2 (1)
    CD80/B7-1 & CD86/B7-2 (2)
    S100A11 (2)
    HLA-A2-peptide (YLEPGPVT) Complex (4)
    Calprotectin (S100A8/9) (3)
    BRAF/B-Raf (5)
    Mavezelimab (1)
    CD137/4-1BB & CD274/PD-L1 (3)
    TRP-1 & CD134/OX40 (1)
  • Especies
    0 seleccionado
    Mus musculus (Mouse) (7)
    Tupaia chinensis (12)
    Homo sapiens (Human) (7)
    Canis lupus familiaris (Dog) (8)
    Dog (3)
    Human (178)
    Felis catus (Cat) (9)
    Cat (1)
    Mouse (27)
    Rat (1)
    Neosartorya fumigata (1)
    Canis lupus familiaris (1)
  • Aplicaciones
    0 seleccionado
    ELISA (844)
    in vivo CTLA-4 neutralization (2)
    GICA (2)
    Neut (1)
    FCM (152)
    IHC (84)
    in vivo (2)
    in vivo intra-tumoral regulatory T cell depletion (2)
    in vivo blockade (2)
    FuncS (18)
    Inhib (1)
    WB (165)
    IFA (4)
    Bioactivity: FACS (153)
    in vivo PD-L1 blockade (3)
    SPR (4)
    IP (2)
    Bioactivity: FACS (1)
    Functional assay (158)
    in vitro PD-L1 blockade (3)
    SDS-PAGE (75)
    Research in vivo (158)
    IHC-F (3)
    FACS (5)
    Inmunógeno (75)
    IF (8)
    Functional assay (6)
    Bioactivity testing in progress (31)
    Research in vivo (4)
    Blocking (2)
    Neutralization (2)
  • Reactividad
    0 seleccionado
    Kryptolebias marmoratus (1)
    Avian retrovirus IC10 (1)
    Carassius auratus (1)
    Chicken (4)
    Limanda limanda (1)
    Avian rous-associated virus type 1 (1)
    Tupaia chinensis (4)
    Cavia porcellus (1)
    Pig (6)
    Mesocricetus auratus (1)
    Bos taurus (8)
    Coturnix japonica (1)
    Mouse (77)
    Cynomolgus monkey (1)
    Dog (13)
    Human (198)
    Pongo abelii (2)
    Cyprinus carpio (1)
    Callithrix jacchus (1)
    Monodelphis domestica (1)
    Oryctolagus cuniculus (4)
    Rhesus macaque (1)
    Mus musculus (Mouse) (1)
    B7-H1 / PD-L1 / CD274 (1)
    Danio rerio (1)
    Capra hircus (1)
    Oryzias latipes (1)
    Macaca mulatta (1)
    Drosophila grimshawi (1)
    Broad-Spectrum (1)
    Xenopus laevis (1)
    Bovine (1)
    Rat (16)
    Neosartorya fumigata (1)
    Drosophila willistoni (1)
    Monkey (5)
    Homo sapiens (Human) (4)
    Cat (1)
    Kirsten murine sarcoma virus (1)
  • Especie huésped
    0 seleccionado
    Alpaca (6)
    HEK293T (1)
    Human (157)
    Mouse (164)
    Dog (2)
    Armenian Hamster (5)
    Rabbit (61)
    Chimeric (5)
    Rat (14)
    Humanized (34)
  • Clonalidad
    0 seleccionado
    Monoclonal (398)
    Polyclonal (53)
  • Conjugado
    0 seleccionado
    FITC (28)
    APC (28)
    PerCP (28)
    Unconjugated (301)
    PE (28)

Acceso rápido

Contáctenos

  • +86-027-65523339

  • info@abinscience.com

  • Edificio C, No. 666, Calle Shendunsi, Wuhan, 430206, China

  • linkedin
  • Ins
  • youtube
  • youtube
Derechos de autor © 2026 abinScience. Todos los derechos reservados. Todos los productos son solo para uso de investigación